Ketanserin in Hypertension

Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors

1981 • 848 citations

Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

1981 • 530 citations

Local modulation of adrenergic neuroeffector interaction in the blood vessel well.

1981 • 417 citations

Serotonin (5-Hydroxytryptamine)

1954 • 298 citations

Mechanism of the Hypotensive Effect of Ketanserin

1982 • 183 citations

Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man.

1978 • 156 citations

ADVERSE REACTIONS TO BENDROFLUAZIDE AND PROPRANOLOL FOR THE TREATMENT OF MILD HYPERTENSION

1981 • 155 citations

Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.

1982 • 104 citations

Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

1982 • 90 citations

Organization and Efficacy of an Out‐Patient Hypertension Clinic

1978 • 58 citations

5-hydroxytryptamine and vascular disease.

1983 • 56 citations

Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent

1982 • 50 citations

Antihypertensive properties of ketanserin (R 41 468).

1983 • 36 citations

The Antihypertensive Effects of Ketanserin (R 41 468), a Novel 5-Hydroxytryptamine-Blocking Agent, in Patients with Essential Hypertension

1981 • 31 citations

Deleted Work

1955 • 0 citations